|
End-of-day quote
New Zealand S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 4.580 NZD | -0.22% |
|
+2.00% | +35.50% |
| 10-05 | ASX Preview: Australian Shares to Rise as Oil Prices Fall; Tower Lifts Fiscal 2026 Profit Guidance | MT |
| 10-05 | AFT Pharmaceuticals on Track for Fiscal 2027 Revenue, Profit Targets | MT |
| Market Cap | 480M 273M 244M 225M 204M 384M 25.79B 389M 2.7B 1.06B 13.55B 1.03B 1B 43.19B | P/E 2027 * |
24.4x | P/E 2028 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 510M 290M 259M 239M 217M 408M 27.39B 413M 2.87B 1.13B 14.4B 1.09B 1.07B 45.88B | EV / Sales 2027 * |
1.68x | EV / Sales 2028 * | 1.46x |
| Free-Float |
22.37% | Yield 2027 * |
0.72% | Yield 2028 * | 0.91% |
| Markets | Quality | ||
|---|---|---|---|
New Zealand S.E.
| AFT | End-of-day quote | |
Australian S.E.
| AFP | Delayed |
Last Transcript: AFT Pharmaceuticals Limited
| 24-01-20 | Rentevrees zet Bel20 onder druk | |
| 24-01-19 | KBC uitblinker op groene beurs | |
| 24-01-19 | Brusselse beurs opent flink hoger | |
| 24-01-19 | Brussel start handelsdag vermoedelijk in het groen | |
| 24-01-18 | Hyloris gaat samenwerken met AFT Pharmaceuticals |
| 1 day | -0.22% | ||
| 1 week | +2.00% | ||
| Current month | +6.51% | ||
| 1 month | +7.01% | ||
| 3 months | +16.24% | ||
| 6 months | +27.93% | ||
| Current year | +35.50% |
| 1 week | 4.4 |  | 4.59 |
| 1 month | 4.21 | | 4.64 |
| Current year | 3.35 | | 4.85 |
| 1 year | 3 | | 4.85 |
| 3 years | 2.37 | | 4.85 |
| 5 years | 2.37 | | 5 |
| 10 years | 1.7 | | 5.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marree Atkinson
HRO | Human Resources Officer | - | 2012-09-03 |
Hartley Atkinson
CEO | Chief Executive Officer | - | 1997-09-03 |
Stuart Houliston
DFI | Director of Finance/CFO | - | 2026-06-14 |
| Director | Title | Age | Since |
|---|---|---|---|
David Flacks
CHM | Chairman | - | 2015-06-21 |
Hartley Atkinson
BRD | Director/Board Member | - | 1997-09-03 |
Marree Atkinson
BRD | Director/Board Member | - | 2012-09-03 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/25 | Buy | Founder | 200,000 | 0.1907% | ||
| 6/26/25 | Free | Founder | 17,755 | 0.0169% | ||
| 12/2/24 | Buy | Founder | 45 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +2.00% | +50.16% | +34.71% | 274M | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 625B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 511B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 366B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 291B | |
| -0.03% | +2.55% | +1.12% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 194B | |
| Average | -0.05% | +3.83% | +36.90% | +65.05% | 400.82B | |
| Weighted average by Cap. | +0.33% | +4.17% | +40.81% | +79.56% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 304M 173M 154M 143M 129M 243M 16.31B 246M 1.71B 671M 8.57B 648M 635M 27.32B | 345M 196M 175M 162M 147M 276M 18.54B 280M 1.94B 762M 9.74B 737M 721M 31.05B |
| Net income | 19.7M 11.21M 9.98M 9.24M 8.37M 15.76M 1.06B 15.95M 111M 43.49M 556M 42.03M 41.16M 1.77B | 24.81M 14.12M 12.58M 11.65M 10.54M 19.86M 1.33B 20.09M 140M 54.79M 700M 52.96M 51.85M 2.23B |
| Net Debt | 29.84M 16.97M 15.13M 14M 12.67M 23.88M 1.6B 24.16M 168M 65.88M 842M 63.68M 62.35M 2.68B | 24.6M 13.99M 12.47M 11.54M 10.45M 19.68M 1.32B 19.92M 138M 54.31M 694M 52.49M 51.4M 2.21B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | NZ$4.580 | -0.22% | 10,656 |
| 26-10-20 | NZ$4.590 | +2.23% | 71,478 |
| 26-10-19 | NZ$4.490 | +0.90% | 16,236 |
| 26-10-16 | NZ$4.450 | +1.14% | 9,398 |
| 26-10-15 | NZ$4.400 | -2.00% | 14,508 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AFT Stock
Select your edition
All financial news and data tailored to specific country editions
